Growth hormone improves cardiac function in rats with experimental myocardial infarction

European Journal of Clinical Investigation

Volumn 27, Issue 6, 1997, Pages 517-525

  Isgaard, J ^a   Kujacic, V ^a   Jennische, E ^b   Holmang A ^c   Sun, X Y ^a   Hedner, T ^a   Hjalmarson, A ^a   Bengtsson, B A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Growth hormone; Insulin like growth factor; Myocardial infarction; Rat

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HORMONE ACTION; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0030755712     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1430692.x     Document Type: Article

References (41)

1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
2. Murphy LJ, Bell GI, Duckworth L, Friesen G. Identification, characterization and regulation of a rat complimentary deoxyribonucleic acid which encodes insulin-like growth factor 1. Endocrinology 1987;121:684-91.
3. Isgaard J, Nilsson A, Vikman K, Isaksson OGP. Growth hormone regulates the level of insulin-like growth factor I in rat skeletal muscle. J Endocrinol 1989;120:107-12.
4. Wåhlander H, Isgaard J, Jennische E, Friberg P. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension 1992;19:25-32.
5. Russell-Jones DL, Leach RM, Ward JPT, Thomas CR. Insulin-like growth factor-I gene expression is increased in the right ventricle hypertrophy induced by chronic hypoxia in the rat. J Endocrinol 1993;10:99-102.
6. Donohue TJ, Dworkin LD, Lango MN et al. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994;89:799-809.
7. Ito H, Hiroe M, Hirata Y et al. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715-21.
8. Donath MY, Zapf J, Eppenherger-Eberhardt M, Froesch ER, Eppenberger HM. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle α-actin of adult cardiomyocytes. Proc Natl Acad Sci USA 1994;91:1686-90.
9. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross Jr J. Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-27.
10. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 1995;92:8031-5.
11. Mathews LS, Engberg B, Norstedt G. Regulation of rat GH receptor gene expression. J Biol Chem 1989;264:9905-10.
12. Isgaard J, Wåhlander H, Adams MA, Friberg P. Increased expression of growth hormone receptor mRNA and insulin-like growth factor I mRNA in volume overloaded hearts. Hypertension 1994;23:884-8.
13. Timsit J, Riou B, Bertherat J et al. Effects of chronic growth hormone hypersecretion on contractility, energetics, isomyosin pattern and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 1990;86:507-15.
14. Mayoux E, Ventura-Clapier R, Timsit J, Béhar-Cohen F, Hoffman C, Mercadier J-J. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Cire Res 1993;72:57-64.
15. Jin H, Yang R, Gillett N, Clark RG, Ko A, Paoni NF. Beneficial effects of growth hormone and insulin-like factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. J Cardiovasc Pharmacol 1995;26:420-5.
16. Amato G, Carella C, Fazio S et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993;77:1671-6.
17. Caidahl K, Edén S, Bengtsson B-Å. Cardiovascular and renal effects of growth hormone. Clin Endocrinol 1994;40:393-400.
18. Valcavi R, Gaddi O, Zini M, Lavicoli M, Mellino U, Portioli I. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Endocrinol Metab 1995;80:659-66.
19. Fazio S, Sabatini D, Capaldo B et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996;334:809-14.
20. Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12.
21. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72:406-12.
22. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994;89:345-54.
23. Sahn DJ, De Maria A, Kisslo JAW. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
24. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-18.
25. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
26. Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, Tow DE. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionucleide techniques. Circulation 1979;60:760-6.
27. Reichek N, Wilson S, St John Sutton M, Palapport TA, Goldberry S, Hirschfeld JW. Non-invasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982;65:99-108.
28. Calafiore P, Stewart WJ. Doppler echocardiographic quantitation of volumetric flow rate. Cardiol Clin 1990;8:191-202.
29. Haites NE, McLennan FM, Mowat DH, Rawles JM. Assessment of cardiac output by the Doppler ultrasound technique alone. Br Heart J 1985;53:123-9.
30. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 1986;83:9343-7.
31. Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts Jr CT, Le Roith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 1989;86:7451-5.
32. Guron G, Friberg P, Wickman A, Brantsing C, Gabrielsson B, Isgaard J. Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension. Hypertension 1996;27:636-42.
33. Durnam DM, Palmiter RD. A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem 1983;131:385-93.
34. Labarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980;102:344-52.
35. Kiernan JA. In: Histological and histochemical methods: theory and practice, 2nd edn. Oxford: Pergamon Press 1990. Chap. 16, pp. 258-287.
36. Cittadini A, Strömer H, Katz SE et al. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. Circulation 1996;93:800-9.
37. 2+ handling and enhance cardiac performance. Circ Res 1996;79:227-36.
38. Yang R, Bunting S, Gillett N, Clark RG, Jin H. Effects of growth hormone in rats with post-infarction left ventricular dysfunction. Cardiovasc Drugs Ther 1995;9:125-31.
39. Duerr RL, McKirnan MD, Gim RD, Clark RG, Chien KR, Ross Jr J. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 1996;93:2188-96.
40. Turner H, Wass JAH. Growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996;335:672.
41. Groesbeck MD, Parlow AF. Highly improved precision of the hypophysectomized female rat body weight gain bioassay for growth hormone by increased frequency of injections, avoidance of antibody formation and other simple modifications. Endocrinology 1987;120:2582-90.